Professional
Added to YB: 2025-03-17
Pitch date: 2024-12-31
DHR [neutral]
Danaher Corporation
-0.52%
current return
Author Info
No bio for this author
Company Info
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
Market Cap
$159.9B
Pitch Price
$229.73
Price Target
N/A
Dividend
0.57%
EV/EBITDA
22.21
P/E
46.51
EV/Sales
7.27
Sector
Life Sciences Tools and Services
Category
N/A
Meridian Hedged Equity Fund Portfolio Holding: Danaher Corporation
DHR (holding update): Global life sciences & diagnostics leader. Strong bioprocessing, med research, clinical diagnostics. Q3 mixed: organic rev beat guidance, missed expectations. Bioprocessing orders strong, life sciences soft. Diagnostics solid on respiratory testing. Near-term challenges, but confident in market leadership & demand capture. Expect operational excellence & M&A to drive value as markets recover.
Read full article (1 min)